Xoft raises $25M for targeted cancer treatment
Xoft, a Sunnyvale, Calif. company with an X-ray radiation treatment used for breast cancer and endometrial cancer, has raised a fifth round totaling $25 million, according to VentureWire.
The treatment uses targeting technology and tools to pinpoint the area being irradiated, limiting the damage done to the patient and allowing technicians to remain in the room.
New investor Chicago Growth Partners provided a majority of the funding, and was joined by previous investors including Easton Capital, Cutlass Capital, Maverick Capital and Sutter Hill Ventures.
Next Story: eASIC announces a 45-nanometer custom design process for smaller fish in chips
Previous Story: Elance introduces new system to manage outsourced work
About the Author, Chris Morrison
Chris Morrison writes about cleantech and environmental issues for VentureBeat, with occasional forays into gaming and semantic technology. He got his start writing about tech for Business 2.0 magazine, but quickly realized new media was the ticket when that institution closed its doors in 2007. Chris has also covered public equities and regulatory issues. He originally hails from southern Virginia, graduated from Evergreen State College in Washington, and now lives in San Francisco.